Home
LIMNW vs REFR Comparison

LIMNW vs REFR Comparison

Compare LIMNW & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LIMNW

REFR

Machine Learning Prediction

ML Decision
LIMNW
REFR

Stock Information

Founded
LIMNW N/A
REFR 1965

Country
LIMNW United States
REFR United States

Employees
LIMNW N/A
REFR N/A

Industry
LIMNW
REFR Multi-Sector Companies

Sector
LIMNW
REFR Miscellaneous

Exchange
LIMNW Nasdaq
REFR Nasdaq

Market Cap
LIMNW N/A
REFR N/A

IPO Year
LIMNW N/A
REFR N/A

Fundamental

Price
LIMNW $0.09
REFR $1.99

Analyst Decision
LIMNW
REFR

Analyst Count
LIMNW 0
REFR 0

Target Price
LIMNW N/A
REFR N/A

AVG Volume (30 Days)
LIMNW N/A
REFR 52.4K

Earning Date
LIMNW N/A
REFR 05-08-2025

Dividend Yield
LIMNW N/A
REFR N/A

EPS Growth
LIMNW N/A
REFR N/A

EPS
LIMNW N/A
REFR N/A

Revenue
LIMNW N/A
REFR $1,581,929.00

Revenue This Year
LIMNW N/A
REFR N/A

Revenue Next Year
LIMNW N/A
REFR N/A

P/E Ratio
LIMNW N/A
REFR N/A

Revenue Growth
LIMNW N/A
REFR 62.28

52 Week Low
LIMNW N/A
REFR $0.93

52 Week High
LIMNW N/A
REFR $2.42

Technical

Relative Strength Index (RSI)
LIMNW N/A
REFR 78.70

Support Level
LIMNW N/A
REFR $1.65

Resistance Level
LIMNW N/A
REFR $2.00

Average True Range (ATR)
LIMNW 0.00
REFR 0.12

MACD
LIMNW 0.00
REFR 0.02

Stochastic Oscillator
LIMNW 0.00
REFR 89.80

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: